TARA Biosystems Taps MyoKardia’s Michael Graziano for CSO Post

Xconomy New York — 

Michael Graziano is joining TARA Biosystems to become the New York company’s chief scientific officer. TARA Biosystems is developing “heart-on-a-chip” tissue models that can be used in drug discovery and drug toxicity testing. Graziano most recently worked at South San Francisco, CA-based MyoKardia (NASDAQ: MYOK), where he was vice president of research biology. Before MyoKardia, Graziano was executive director of cardiovascular research at Merck (NYSE: MRK).